Tandem Diabetes Care (STU:TD5A) Change In Payables And Accrued Expense : €1.2 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Tandem Diabetes Care Change In Payables And Accrued Expense?

Tandem Diabetes Care's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was €-1.1 Mil. It means Tandem Diabetes Care's Accounts Payable & Accrued Expense declined by €1.1 Mil from Jun. 2024 to Sep. 2024 .

Tandem Diabetes Care's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €-2.1 Mil. It means Tandem Diabetes Care's Accounts Payable & Accrued Expense declined by €2.1 Mil from Dec. 2022 to Dec. 2023 .

Tandem Diabetes Care Change In Payables And Accrued Expense Historical Data

The historical data trend for Tandem Diabetes Care's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Change In Payables And Accrued Expense Chart

Tandem Diabetes Care Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

11.69

-1.76

13.20

22.69

-2.13

Tandem Diabetes Care Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-9.49	2.06	-3.10	3.35	-1.08

Tandem Diabetes Care Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.2 Mil.

Tandem Diabetes Care Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Tandem Diabetes Care Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (STU:TD5A) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

TNDM:USA TNDM:Mexico 0M0F:UK

Address

12400 High Bluff Drive, San Diego, CA, USA, 92130

Website

https://www.tandemdiabetes.com

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care Headlines

No Headlines